Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
autologous cd34+ cells (1 trial)
beta-Thalassemia (Phase 2)
Thalassemia (Phase 2)
Trials (1 total)
Trial APIs (1 total)